Alexis Vaujany is an associate in the Latham & Watkins' Paris office and a member of the firm's Healthcare & Life Sciences Practice. He primarily advises multinational companies and startups in the pharmaceutical, biotech, medical devices, cosmetics, and food and beverage sectors on a broad variety of complex European, domestic, and cross-border regulatory matters, including products approvals, market access, promotion and advertising, post-market obligations, cannabis-related matters, and general compliance matters.

Bar Qualification

  • Avocat (Paris)

Education

  • PhD in Pharmaceutical Law in Law and Criminal Sciences, University of Montpellier
microbiological pipette in the genetic laboratory
April 15, 2025 Our Work

Latham Advises Norgine on Acquisition of Theravia

A cross-border team represents Norgine in its acquisition of an international pharmaceutical company specializing in cutting-edge treatments for patients with rare and debilitating conditions.
Pipetting a DNA (deoxyribonucleic acid) sample into a multiwell plate with DNA information in the background
January 13, 2025 Resource

Healthcare & Life Sciences Market Update

In this edition, we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market.